NeuroSense Therapeutics L... (NRSN)

AI Score

Unlock

1.00

0.00 (0.00%)

At close: Apr 25, 2025, 3:59 PM

1.00

-0.01%

After-hours: Apr 25, 2025, 07:54 PM EDT

NeuroSense Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-1.77M	-2.11M	-3.03M	-2.99M	-3.29M	-2.9M	-3.48M	-3.64M	-3.38M	-3.32M	-3.59M	-3.26M	-1.65M	-880K	-951K	-2.11M	-1.12M	-1.12M	-325K	-325K
Interest Income	n/a	n/a	2.17M	n/a	n/a	3.69M	138K	62K	n/a	335K	144K	572K	n/a	n/a	11K	n/a	n/a	n/a	n/a	n/a
Pretax Income	-1.8M	-2.15M	-857K	-5.4M	-2.95M	784K	-5.22M	-3.89M	-3.15M	-2.99M	-3.48M	-2.71M	-101K	-888K	-928K	-2.12M	-1.1M	-1.1M	-311K	-311K
Net Income	-1.8M	-2.15M	-857K	-5.4M	-2.95M	784K	-5.22M	-3.83M	-2.97M	-2.66M	-3.34M	-2.14M	-101K	-888K	-928K	-2.12M	-1.1M	-1.1M	-311K	-311K
Selling & General & Admin	685K	946K	1.46M	1.11M	1.33M	1.27M	1.57M	1.54M	1.83M	1.61M	1.72M	1.97M	1.6M	361K	453K	92K	138.5K	138.5K	58K	58K
Research & Development	1.09M	1.16M	1.57M	1.88M	1.96M	1.63M	1.91M	2.1M	1.54M	1.71M	1.87M	1.3M	46K	519K	498K	2.02M	980.5K	980.5K	267K	267K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.77M	2.11M	3.03M	2.99M	3.29M	2.9M	3.48M	3.64M	3.38M	3.32M	3.59M	3.26M	1.65M	880K	951K	2.11M	1.1M	1.1M	311K	311K
Interest Expense	n/a	n/a	n/a	2.41M	n/a	2.2M	1.89M	310K	n/a	10K	35K	23K	n/a	n/a	n/a	13K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.77M	2.11M	3.03M	2.99M	3.29M	2.9M	3.48M	3.64M	3.38M	3.32M	3.59M	3.26M	1.65M	880K	951K	2.11M	1.1M	1.1M	311K	311K
Income Tax Expense	n/a	n/a	n/a	-43.28K	-1	5.92M	-2.17M	-62K	-176K	-335K	-144K	-572K	-3.75K	-8.75K	10.25K	-750	n/a	16K	14K	14K
Shares Outstanding (Basic)	19.21M	19.21M	18.06M	15.41M	15.38M	13.62M	13.62M	11.78M	11.78M	11.59M	11.28M	10.99M	10.94M	10.77M	10.94M	10.94M	5.58M	5.58M	5.45M	5.45M
Shares Outstanding (Diluted)	19.21M	19.21M	18.06M	15.41M	15.38M	13.62M	13.62M	11.78M	11.78M	11.59M	11.28M	11.31M	10.94M	10.77M	10.94M	10.94M	5.58M	5.58M	5.45M	5.45M
EPS (Basic)	-0.09	-0.11	-0.05	-0.35	-0.19	0.06	-0.38	-0.32	-0.25	-0.23	-0.3	-0.19	-0.01	-0.08	-0.08	-0.19	-0.2	-0.2	-0.06	-0.06
EPS (Diluted)	-0.09	-0.11	-0.05	-0.35	-0.19	0.06	-0.38	-0.32	-0.25	-0.23	-0.3	-0.19	-0.01	-0.08	-0.08	-0.19	-0.2	-0.2	-0.06	-0.06
EBITDA	-1.77M	-2.11M	-3.03M	-2.99M	-5.15M	796K	-5.53M	-3.58M	-3.15M	-2.98M	-3.45M	-2.69M	-1.64M	-879.25K	-950.25K	-2.11M	-1.12M	16K	14K	14K
EBIT	-1.77M	-2.11M	-3.03M	-2.99M	-5.15M	2.99M	-5.53M	-3.58M	-3.2M	-2.98M	-3.45M	-2.69M	-1.65M	-888K	-940K	-2.11M	n/a	n/a	n/a	n/a
Depreciation & Amortization	n/a	n/a	n/a	5.25K	5.25K	3K	23.5K	3K	3K	750.00	20.5K	750.00	750.00	750.00	750.00	750.00	750.00	1.12M	325K	325K